Further analysis demonstrated that dapagliflozin increased the likelihood of regression in patients with a UACR of 300 or more in 3,860 patients…

Although approximately 60% of patients with diffuse large B-cell lymphoma (DLBCL) can be cured, the remaining 40% have relapsed or refractory disease (R/R DLBCL). Substantial unmet need remains for effective, safe therapies for these patients. Novel targeted approaches to the treatment of R/R DLBCL include CD19-directed antibodies, antibody–drug conjugates, bispecific monoclonal antibodies, and anti-CD-19 chimeric antigen receptor (CAR) T-cell therapies.

A number of misconceptions prevail in nail melanoma. This short essay tries to clarify some of these issues.

Interviewing Peter Lio, Clinical Assistant Professor of Dermatology and Pediatrics, Northwestern University Feinberg School of Medicine

Since December 2019, the new severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) from Wuhan, China, has been the aetiological agent of COVID-19 disease, an infectious disease that has evolved into a global pandemic.1 Androgenetic alopecia (AGA), the most common type of alopecia,2 is an androgen-dependent condition, the main androgen responsible for the follicular pathology being dihydrotestosterone.3

THE EUROPEAN Academy of Dermatology and Venereology (EADV) 2021 Virtual Congress successfully brought together influential clinicians and academics from across the globe, working to achieve the EADV’s aims of “improving the quality of patient care, furthering knowledge and education of dermatologists and venereologists globally through innovation, and advocating on behalf of the speciality and patients.” Rather than viewing the online conference as an obligation, born out of necessity during the COVID-19 pandemic, the EADV instead transformed it into an opportunity. This was underscored by Alexander Stratigos, President of the EADV, during the welcome address: “As we move toward a post-pandemic era, our Academy is emerging ever stronger, with a vibrant day-to-day education programme that exploits the unique opportunities presented by digital learning.” Stratigos added: “Through our evolving digital learning ecosystem, we are able to deliver a multitude of online experiences, including webinars, enhanced digital communications, e-learning, and web-based tools to support continuous medical education and allow a broader diffusion of knowledge.”

The latest international guidelines on urticaria were published in September as a joint initiative from the European Academy of…